BioRestorative Therapies, Inc. (OTCMKTS:BRTXQ – Get Free Report) traded down 0.1% during mid-day trading on Tuesday . The company traded as low as $0.3901 and last traded at $0.4090. Approximately 650,071 shares were traded during mid-day trading, a decline of 99% from the average session volume of 62,169,492 shares. The stock had previously closed at $0.4096.
BioRestorative Therapies Stock Performance
The stock’s 50 day moving average price is $0.29 and its 200 day moving average price is $0.57. The company has a market capitalization of $651.26 million, a P/E ratio of -0.37 and a beta of 102.36.
About BioRestorative Therapies
BioRestorative Therapies, Inc is a clinical‐stage regenerative medicine company focused on developing and commercializing advanced therapeutic platforms to promote tissue repair and healing. The company’s principal business activities are conducted through its wholly owned subsidiary, TissueForm, Inc, which holds the rights to a proprietary micro‐fiber scaffold technology designed to create a three‐dimensional matrix supporting cell migration, proliferation and new tissue formation. BioRestorative’s work is primarily targeted at chronic and non‐healing wounds, including diabetic foot ulcers and other complex soft‐tissue injuries.
The cornerstone of BioRestorative’s product pipeline is the TissueForm® line of scaffold materials.
Read More
- Five stocks we like better than BioRestorative Therapies
- MDA Space Targets US Defense Market With $620M Acquisition
- Carnival’s Second Quarter: Is the Stock Still Complicated?
- Domino’s Stock Slides to 52-Week Low as Investors Digest CEO Change
- Microsoft Solves AI’s Biggest Bottleneck With Chevron Deal
Receive News & Ratings for BioRestorative Therapies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRestorative Therapies and related companies with MarketBeat.com's FREE daily email newsletter.
